 | • レポートコード：MRC2102QY10371 • 出版社/出版日：QYResearch / 2021年1月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場について種類別（リンパルザ、ゼジュラ、ルブラカ、タルゼンナ、その他）、用途別（卵巣がん、乳がん、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・PARP（ポリADPリボースポリメラーゼ）阻害剤市場の概要 ・世界の主要地域別PARP（ポリADPリボースポリメラーゼ）阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場規模2015-2026：種類別（リンパルザ、ゼジュラ、ルブラカ、タルゼンナ、その他） ・世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場規模2015-2026：用途別（卵巣がん、乳がん、その他） ・PARP（ポリADPリボースポリメラーゼ）阻害剤の米国市場規模2015-2020 ・PARP（ポリADPリボースポリメラーゼ）阻害剤のヨーロッパ市場規模2015-2020 ・PARP（ポリADPリボースポリメラーゼ）阻害剤の中国市場規模2015-2020 ・PARP（ポリADPリボースポリメラーゼ）阻害剤の日本市場規模2015-2020 ・PARP（ポリADPリボースポリメラーゼ）阻害剤の東南アジア市場規模2015-2020 ・PARP（ポリADPリボースポリメラーゼ）阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・PARP（ポリADPリボースポリメラーゼ）阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・PARP（ポリADPリボースポリメラーゼ）阻害剤の市場動向・機会・課題 ・調査の結論 |
PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).
They are developed for multiple indications; the most important is the treatment of cancer. Several forms of cancer are more dependent on PARP than regular cells, making PARP an attractive target for cancer therapy. PARP inhibitors appear to improve progression-free survival in women with recurrent platinum-sensitive ovarian cancer, as evidenced mainly by olaparib added to conventional treatment.
PARP (Poly ADP-Ribose Polymerase) Inhibitor first approval in United States in 2014. And in the last several years, global market (value) of PARP (Poly ADP-Ribose Polymerase) Inhibitor developed rapidly, with an average growth rate of 133.8% during 2015 to 2018.
Market Analysis and Insights: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market
The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size is projected to reach US$ 16180 million by 2026, from US$ 2949.5 million in 2020, at a CAGR of 32.8% during 2021-2026.
Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Scope and Market Size
The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the PARP (Poly ADP-Ribose Polymerase) Inhibitor market is segmented into
Lynparza
Zejula
Rubraca
Talzenna
Other
Segment by Application, the PARP (Poly ADP-Ribose Polymerase) Inhibitor market is segmented into
Ovarian Cancer
Breast Cancer
Other
The PARP (Poly ADP-Ribose Polymerase) Inhibitor market is analysed and market size information is provided by regions (countries). Segment by Application, the PARP (Poly ADP-Ribose Polymerase) Inhibitor market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share Analysis
PARP (Poly ADP-Ribose Polymerase) Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in PARP (Poly ADP-Ribose Polymerase) Inhibitor business, the date to enter into the PARP (Poly ADP-Ribose Polymerase) Inhibitor market, PARP (Poly ADP-Ribose Polymerase) Inhibitor product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Tesaro
Merck & Co
Clovis Oncology
Pfizer
1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview
1.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Scope
1.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Type
1.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Type (2020-2026)
1.2.2 Lynparza
1.2.3 Zejula
1.2.4 Rubraca
1.2.5 Talzenna
1.2.6 Other
1.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Segment by Application
1.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Comparison by Application (2020-2026)
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Estimates and Forecasts (2015-2026)
1.4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Growth Rate (2015-2026)
1.4.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Growth Rate (2015-2026)
1.4.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price Trends (2015-2026)
2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Estimate and Forecast by Region
2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Region (2015-2020)
2.2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Region (2015-2020)
2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Estimates and Projections (2015-2026)
2.4.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Estimates and Projections (2015-2026)
2.4.3 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Estimates and Projections (2015-2026)
2.4.4 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Estimates and Projections (2015-2026)
2.4.5 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Estimates and Projections (2015-2026)
2.4.6 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Estimates and Projections (2015-2026)
3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Competition Landscape by Players
3.1 Global Top PARP (Poly ADP-Ribose Polymerase) Inhibitor Players by Sales (2015-2020)
3.2 Global Top PARP (Poly ADP-Ribose Polymerase) Inhibitor Players by Revenue (2015-2020)
3.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor as of 2019)
3.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Price by Company (2015-2020)
3.5 Manufacturers PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key PARP (Poly ADP-Ribose Polymerase) Inhibitor Players (Opinion Leaders)
4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type
4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Historic Market Review by Type (2015-2020)
4.1.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
4.1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Type (2015-2020)
4.1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price by Type (2015-2020)
4.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price Forecast by Type (2021-2026)
5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application
5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Historic Market Review by Application (2015-2020)
5.1.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
5.1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Application (2015-2020)
5.1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price by Application (2015-2020)
5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price Forecast by Application (2021-2026)
6 United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures
6.1 United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
6.2 United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
6.3 United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
7 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures
7.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
7.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
7.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
8 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures
8.1 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
8.2 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
8.3 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
9 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures
9.1 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (3015-3030)
9.2 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
9.3 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
10 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures
10.1 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
10.2 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
10.3 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
11 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Facts & Figures
11.1 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
11.2 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
11.3 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Tesaro
12.2.1 Tesaro Corporation Information
12.2.2 Tesaro Business Overview
12.2.3 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Products Offered
12.2.5 Tesaro Recent Development
12.3 Merck & Co
12.3.1 Merck & Co Corporation Information
12.3.2 Merck & Co Business Overview
12.3.3 Merck & Co PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck & Co PARP (Poly ADP-Ribose Polymerase) Inhibitor Products Offered
12.3.5 Merck & Co Recent Development
12.4 Clovis Oncology
12.4.1 Clovis Oncology Corporation Information
12.4.2 Clovis Oncology Business Overview
12.4.3 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Products Offered
12.4.5 Clovis Oncology Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer PARP (Poly ADP-Ribose Polymerase) Inhibitor Products Offered
12.5.5 Pfizer Recent Development
…
13 PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturing Cost Analysis
13.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor
13.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Distributors List
14.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Customers
15 Market Dynamics
15.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Trends
15.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Opportunities and Drivers
15.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Challenges
15.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Region (2015-2020)
Table 5. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Region (2015-2020)
Table 6. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Region (2015-2020)
Table 8. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share Forecast by Region (2021-2026)
Table 10. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share Forecast by Region (2021-2026)
Table 12. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor (K Units) of Key Companies (2015-2020)
Table 13. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Share by Company (2015-2020)
Table 14. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (US$ Million) by Company (2015-2020)
Table 15. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Company (2015-2020)
Table 16. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor as of 2019)
Table 17. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturing Sites and Area Served
Table 19. Manufacturers PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key PARP (Poly ADP-Ribose Polymerase) Inhibitor Players
Table 22. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Type (2015-2020)
Table 23. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Share by Type (2015-2020)
Table 24. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price (K Units) by Type (2015-2020)
Table 26. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Share by Type (2021-2026)
Table 27. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Type (2021-2026)
Table 29. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price (K Units) by Type (2021-2026)
Table 30. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Application (2015-2020)
Table 31. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Share by Application (2015-2020)
Table 32. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price (K Units) by Application (2015-2020)
Table 34. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Application (2021-2026)
Table 35. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Share by Application (2021-2026)
Table 36. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Application (2021-2026)
Table 38. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price (K Units) by Application (2021-2026)
Table 39. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Company (2015-2020)
Table 40. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
Table 41. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Type (2015-2020)
Table 42. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
Table 43. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Application (2015-2020)
Table 44. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
Table 45. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Company (2015-2020)
Table 46. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
Table 47. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Type (2015-2020)
Table 48. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
Table 49. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Application (2015-2020)
Table 50. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
Table 51. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Company (2015-2020)
Table 52. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
Table 53. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Type (2015-2020)
Table 54. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
Table 55. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Application (2015-2020)
Table 56. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
Table 57. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Company (2015-2020)
Table 58. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
Table 59. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Type (2015-2020)
Table 60. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
Table 61. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Application (2015-2020)
Table 62. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
Table 69. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Company (2015-2020)
Table 70. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company (2015-2020)
Table 71. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Type (2015-2020)
Table 72. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type (2015-2020)
Table 73. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) by Application (2015-2020)
Table 74. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Product
Table 79. AstraZeneca Recent Development
Table 80. Tesaro Corporation Information
Table 81. Tesaro Description and Business Overview
Table 82. Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Product
Table 84. Tesaro Recent Development
Table 85. Merck & Co Corporation Information
Table 86. Merck & Co Description and Business Overview
Table 87. Merck & Co PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merck & Co PARP (Poly ADP-Ribose Polymerase) Inhibitor Product
Table 89. Merck & Co Recent Development
Table 90. Clovis Oncology Corporation Information
Table 91. Clovis Oncology Description and Business Overview
Table 92. Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Product
Table 94. Clovis Oncology Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Pfizer PARP (Poly ADP-Ribose Polymerase) Inhibitor Product
Table 99. Pfizer Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. PARP (Poly ADP-Ribose Polymerase) Inhibitor Distributors List
Table 103. PARP (Poly ADP-Ribose Polymerase) Inhibitor Customers List
Table 104. PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Key Trends
Table 105. PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Opportunities and Drivers
Table 106. PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Picture
Figure 2. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application in 2020 & 2026
Figure 6. Ovarian Cancer Examples
Figure 7. Breast Cancer Examples
Figure 8. Other Examples
Figure 9. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest PARP (Poly ADP-Ribose Polymerase) Inhibitor Players Market Share by Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor 2015 & 2019
Figure 27. PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Type (2015-2020)
Figure 29. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Share by Application (2015-2020)
Figure 31. Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type in 2019
Figure 33. United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type in 2019
Figure 34. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company in 2019
Figure 35. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type in 2019
Figure 36. Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application in 2019
Figure 37. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company in 2019
Figure 38. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type in 2019
Figure 39. China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application in 2019
Figure 40. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company in 2019
Figure 41. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type in 2019
Figure 42. Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application in 2019
Figure 43. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company in 2019
Figure 44. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type in 2019
Figure 45. Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application in 2019
Figure 46. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Company in 2019
Figure 47. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Type in 2019
Figure 48. India PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of PARP (Poly ADP-Ribose Polymerase) Inhibitor
Figure 51. Manufacturing Process Analysis of PARP (Poly ADP-Ribose Polymerase) Inhibitor
Figure 52. PARP (Poly ADP-Ribose Polymerase) Inhibitor Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
D-リボースの世界市場レポート2020 Market Analysis and Insights: Global D-Ribose Market The global D-Ribose market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global D-Ribose Scope and Market Size The global D-Ribose market is segmented by company, region (country…- デジタルポリメラーゼ連鎖反応（dPCR）の世界市場レポート2020 Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a f…
- プラスミノーゲンアクチベーター阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Plasminogen Activator Inhibitor Market The global Plasminogen Activator Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Plasminogen Activator Inhibitor Scope and Market Siz…
- プロテインキナーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Protein Kinase Inhibitor Market The global Protein Kinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Protein Kinase Inhibitor Scope and Market Size The global Protein …
- プロトンポンプ阻害薬の世界市場レポート2020 Market Analysis and Insights: Global Proton Pump Inhibitor Drug Market The global Proton Pump Inhibitor Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Proton Pump Inhibitor Drug Scope and Market Size The global Pr…